EMEA-001701-PIP01-14-M02
Key facts
| Invented name |
Myalepta
|
| Active substance |
Metreleptin
|
| Therapeutic area |
Endocrinology, -gynacology-fertility-metabolism
|
| Decision number |
P/0389/2021
|
| PIP number |
EMEA-001701-PIP01-14-M02
|
| Pharmaceutical form(s) |
Powder for solution for injection
|
| Condition(s) / indication(s) |
Treatment of lipodystrophy
|
| Route(s) of administration |
Subcutaneous use
|
| Contact for public enquiries |
Amryt Pharmaceuticals DAC
Tel. +44 1604 549 952 |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|